The neurometabolic landscape of cognitive decline: In vivo studies with positron emission tomography in Alzheimer's disease

International Journal of Psychophysiology

Volumn 37, Issue 1, 2000, Pages 87-98

  Pietrini, Pietro ^a,b   Alexander, Gene E ^b   Furey, Maura L ^c   Hampel, Harald ^d   Guazzelli, Mario ^e  

^a UNIVERSITY OF PISA   (Italy)

^b Department of Chemistry and Biochemistry   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d Geriatric Psychiat Br   (Germany)

^e Pharmacol Neurbio B   (Italy)

Author keywords

Brain metabolism; Cognition; Dementia; Early diagnosis; Human; Synaptic dysfunction

Indexed keywords

ALZHEIMER DISEASE; BRAIN METABOLISM; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE SEVERITY; EARLY DIAGNOSIS; GLUCOSE BRAIN LEVEL; HUMAN; IN VIVO STUDY; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; DEMENTIA; GLUCOSE; HUMANS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034237167     PISSN: 01678760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8760(00)00097-0     Document Type: Conference Paper

References (58)

1. Alexander G.E., Moeller R. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function in disease. Hum. Brain Mapp. 2:1994;79-94.
2. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex. 1:1991;103-116.
3. Azari N.P., Pettigrew K.D., Schapiro M.B. et al. Early detection of Alzheimer s disease: a statistical approach using positron emission tomographic data. J. Cereb. Blood Flow Metab. 13:1993;438-447.
4. Azari N.P., Pietrini P. Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more? J. Neurol. 242:1995;112-114.
5. Bachman D.L., Wolf P.A., Linn R. et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology. 42:1992;115-119.
6. Chui H.C. Dementia: a review emphasizing clinicopathologic correlation and brain-behavior relationships. Arch. Neurol. 46:1989;806-814.
7. Coyle J.T., Oster-Granite M.L., Gearhart J.D. The neurobiological consequences of Down syndrome. Brain Res. Bull. 16:1986;773-787.
8. Dani A., Pietrini P., Furey M. et al. Brain cognition and metabolism in Down syndrome adults in association with development of dementia. Neuroreport. 7:1996;2933-2936.
9. DeCarli C., Haxby J.V., Gillette J.A., Teichberg D., Rapoport S.I., Schapiro M.B. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology. 42:1992;2029-2036.
10. Duara R., Grady C.L., Haxby J.V. et al. Positron emission tomography in Alzheimer's disease. Neurology. 36:1986;879-887.
11. Evans D.A., Funkenstein H.H., Albert M.S. et al. Prevalence of Alzheimer's disease in a community population of older persons. J. Am. Med. Assoc. 262:1989;2551-2556.
12. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental State: a pratical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
13. Furey-Kurkjian M.L., Pietrini P., Graff-Radford N.R. et al. Visual variant of Alzheimer disease: distinctive neuropsychological features. Neuropsychology. 10:1996;294-300.
14. Furey M.L., Pietrini P., Haxby J.V. et al. Cholinergic modulation alters performance and task-specific rCBF during working memory. Proc. Natl. Acad. Sci. 94:1997;6512-6516.
15. Furey M.L., Pietrini P., Alexander G.E., Freo U., Schapiro M.B., Horwitz B. Cholinergic enhancement improves performance on working memory by modulating the functional activity in distrinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans. Brain Res. Bull. 51(3):2000;213-218.
16. Grady C.L., Rapoport S.I. Cerebral metabolism in aging and dementia. Birren J., Sloane R.B., Cohen G. Handbook of Mental Health and Aging. 1992;201-228 Academic Press, San Diego.
17. Grady C.L., Haxby J.V., Horwitz B. et al. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 10:1988;576-596.
18. Grady C.L., Haxby J.V., Schapiro M.B. et al. Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J. Neuropsychiatry Clin. Neurosci. 2:1990;373-384.
19. Haxby J.V., Schapiro M.B. Longitudinal study of neuropsychological function in older adults with Down Syndrome. Epstein C., Nadel L. Down Syndrome and Alzheimer Disease. 1992;35-50 Wiley-Liss, New York.
20. Haxby J.V., Duara R., Grady C.L., Rapoport S.I., Cutler N.R. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cereb. Blood Flow Metab. 5:1985;193-200.
21. Haxby J.V., Grady C.L., Koss E. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47:1990;753-760.
22. Holcomb H.H., Links J., Smith C., Wong D. Positron emission tomography measuring the metabolic and neurochemical characteristics of the living human nervous system. Andreasen N.C. Brain Imaging Applications in Psychiatry. 1989;235-370 American Psychiatric Press, Washington D.C.
23. Holland A.J., Oliver C. Down's syndrome and the links with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 39:1995;111-114.
24. Ibáñez V., Pietrini P., Alexander G.E. et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology. 50:1998;1585-1593.
25. Jeuptner M., Weiller C. Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage. 2:1995;148-156.
26. Kadekaro M., Crane A.M., Sokoloff L. Differential effects of electric stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc. Natl. Acad. Sci. USA. 82:1985;6010-6013.
27. Kadekaro M., Vance W.H., Terrell M.L., Gary H., Eisenberg H.M., Sokoloff L. Effects of antidromic stimulation of the ventral root on glucose utilization in the ventral horn of the spinal cord in the rat. Proc. Natl. Acad. Sci. USA. 84:1987;5492-5495.
28. Kety S.S. Circulation and metabolism of the human brain. Brain Res. Bull. 50:1999;415-416.
29. Kumar A., Schapiro M.B., Grady C.L. et al. High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology. 4:1991;35-46.
30. Lai F., Williams R.S. A prospective study of Alzheimer's disease in Down syndrome. Arch. Neurol. 46:1989;849-853.
31. Mata M., Fink D.J., Gainer H. et al. Activity-dependent energy metabolism in rat posterior pituitary reflects sodium pump activity. J. Neurochem. 34:1980;213-215.
32. Mazziotta J.C., Phelps M.E., Miller J. Tomographic mapping of human cerebral metabolism normal unstimulated state. Neurology. 31:1981;503-516.
33. Mazziotta J.C., Phelps M.E., Carson R.E., Kuhl D.E. Tomographic mapping of human cerebral metabolism auditory stimulation. Neurology. 32:1982;921-937.
34. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
35. Pietrini P., Azari N.P., Grady C.L. et al. Pattern of cerebral metabolic interactions in a subject at risk for Alzheimer's disease disease: a longitudinal evaluation. Dementia. 4:1993;94-101.
36. Pietrini P., Furey M.L., Graff-Radford N. et al. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Am. J. Psychiatry. 153:1996;1261-1268.
37. Pietrini, P., Hof, P., Graff-Radford, N.R., Furey, M.L., Alexander, G.E., Mentis, M.J., Nichelli, P., Dani, A., Brown, C.A., Schapiro, M.B., 1997a. Altered regional distribution of brain metabolic and patholological lesions in the visual variant of Alzheimer Disease (AD). 27th Annual Meeting of the Society for Neuroscience. Abstract Book, 23, p. 2170.
38. Pietrini P., Dani A., Furey M.L. et al. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. Am. J. Psychiatry. 154(8):1997;1063-1069.
39. Pietrini P., Dani A., Raphaelson M. et al. Cerebral glucose metabolic and neuropsychological dysfunction in patients with untreated Sleep Apnea Syndrome. Sleep. 21S:1998;82.
40. Pietrini, P., Guazzelli, M., Jaffe, K., Sandhu, N., Grafman, J., 1998b. Brain response during imaginal aggressive behavior in healthy young male and female subjects: a PET-rCBF study. Society for Neuroscience Abstracts 24, 1, 781.
41. Pietrini P., Furey M.L., Guazzelli M. In vivo biochemistry of the brain in understanding human cognition and emotions: towards a molecular psychology. Brain Res. Bull. 50:1999;417-418.
42. Pietrini P., Furey M.L., Alexander G.E. et al. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. Am. J. Psychiatry. 156:1999;470-473.
43. Pietrini P., Rapoport S.I. Functional brain imaging: cerebral blood flow and glucose metabolism in healthy human aging. Coffey C.E., Cumming J.L. Textbook of Geriatric Neuropsychiatry, 2nd ed. 2000;239-265 American Psychiatric Press, Washington, D.C., USA.
44. Pietrini, P., Furey, M.L., Alexander, G.E., Dani, A., Mentis, M.J., Horwitz, B., Guazzelli, M., Schapiro, M.B., Rapoport, S.I., 2000. Cerebral metabolic response to passive audiovisual stimulation in Alzheimer disease patients and healthy controls assessed by positron emission tomography. J. Nucl. Med. 41.
45. Rapoport S.I. Neurobiology of primary dementia. Folstein M.F. Neurobiology of primary dementia. 1998;235-270 American Psychiatric Press, Washington D.C.
46. Rapoport S.I. How did the human brain evolve? A proposal based on new evidence from in vivo brain imaging during attention and ideation. Brain Res. Bull. 50:1999;149-166.
47. Reiman E.M., Caselli R.J., Yun L.S. et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N. Engl. J. Med. 334:1996;752-758.
48. 18F fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ. Res. 44:1979;127-137.
49. Rogers S.L., Farlow M.R., Doody R.S., Mohs R., Friedhoff L.T. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease Donepezil Study Group. Neurology. 50:1998;136-145.
50. Roland P.E. Brain Activation. 1993;Wiley-Liss, New York.
51. Rusinek H., deLeon M.J., George A.E. et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology. 178:1991;109-114.
52. Schapiro M.B., Grady C.L., Haxby J.V. Nature of mental retardation and dementia in Down's syndrome study with PET CT and neuropsychology. Neurobiol. Aging. 13:1992;723-734.
53. Schwartz W.J., Smith C.G., Davidsen L. et al. Metabolic mapping of functional activity in the hypotalamo-neurohypophysial system of the rat. Science. 205:1979;723-725.
54. Small G.W., Mazziotta J.C., Collins M.T. et al. Apolipoprotein E type allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. J. Am. Med. Assoc. 273:1995;942-947.
55. Sokoloff L. Relationships among local functional activity energy metabolism and blood flow in the central nervous system. Fed. Proc. 40:1981;2311-2316.
56. 14C-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:1977;897-916.
57. Whittam R. The dependence of the respiration of brain cortex on active cation transport. Biochem. J. 82:1962;205-212.
58. Yarowsky P., Ingvar D.H. Neuronal activity and energy metabolism. Fed. Proc. 40:1981;2353-2362.